These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18307313)

  • 1. Antimicrobial peptides with stability toward tryptic degradation.
    Svenson J; Stensen W; Brandsdal BO; Haug BE; Monrad J; Svendsen JS
    Biochemistry; 2008 Mar; 47(12):3777-88. PubMed ID: 18307313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the S1 and S3 subsite of trypsin with unnatural cationic amino acids generates antimicrobial peptides with potential for oral administration.
    Karstad R; Isaksen G; Wynendaele E; Guttormsen Y; De Spiegeleer B; Brandsdal BO; Svendsen JS; Svenson J
    J Med Chem; 2012 Jul; 55(14):6294-305. PubMed ID: 22720778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unnatural amino acid side chains as S1, S1', and S2' probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation.
    Karstad R; Isaksen G; Brandsdal BO; Svendsen JS; Svenson J
    J Med Chem; 2010 Aug; 53(15):5558-66. PubMed ID: 20608742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered activity and physicochemical properties of short cationic antimicrobial peptides by incorporation of arginine analogues.
    Svenson J; Karstad R; Flaten GE; Brandsdal BO; Brandl M; Svendsen JS
    Mol Pharm; 2009; 6(3):996-1005. PubMed ID: 19341291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability.
    Svenson J; Vergote V; Karstad R; Burvenich C; Svendsen JS; De Spiegeleer B
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1032-9. PubMed ID: 19952307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides.
    Tsai CW; Hsu NY; Wang CH; Lu CY; Chang Y; Tsai HH; Ruaan RC
    J Mol Biol; 2009 Sep; 392(3):837-54. PubMed ID: 19576903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect.
    Svenson J; Brandsdal BO; Stensen W; Svendsen JS
    J Med Chem; 2007 Jul; 50(14):3334-9. PubMed ID: 17569519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction.
    Hilpert K; Fjell CD; Cherkasov A
    Methods Mol Biol; 2008; 494():127-59. PubMed ID: 18726572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides.
    Flaten GE; Kottra G; Stensen W; Isaksen G; Karstad R; Svendsen JS; Daniel H; Svenson J
    J Med Chem; 2011 Apr; 54(7):2422-32. PubMed ID: 21401113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR modeling and computer-aided design of antimicrobial peptides.
    Jenssen H; Fjell CD; Cherkasov A; Hancock RE
    J Pept Sci; 2008 Jan; 14(1):110-4. PubMed ID: 17847019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometric identification of the trypsin cleavage pathway in lysyl-proline containing oligotuftsin peptides.
    Manea M; Mezo G; Hudecz F; Przybylski M
    J Pept Sci; 2007 Apr; 13(4):227-36. PubMed ID: 17394121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptic Stability of Synthetic Bactenecin Derivatives Is Determined by the Side Chain Length of Cationic Residues and the Peptide Conformation.
    Bagheri M; Arasteh S; Haney EF; Hancock RE
    J Med Chem; 2016 Apr; 59(7):3079-86. PubMed ID: 26958984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1.
    Gottler LM; de la Salud Bea R; Shelburne CE; Ramamoorthy A; Marsh EN
    Biochemistry; 2008 Sep; 47(35):9243-50. PubMed ID: 18693751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
    Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
    Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial glycoprofiling by using random sequence peptide microarrays.
    Morales Betanzos C; Gonzalez-Moa MJ; Boltz KW; Vander Werf BD; Johnston SA; Svarovsky SA
    Chembiochem; 2009 Mar; 10(5):877-88. PubMed ID: 19243087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic antimicrobial peptidomimetics with therapeutic potential.
    Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
    J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of antibacterial action of dermaseptin B2: interplay between helix-hinge-helix structure and membrane curvature strain.
    Galanth C; Abbassi F; Lequin O; Ayala-Sanmartin J; Ladram A; Nicolas P; Amiche M
    Biochemistry; 2009 Jan; 48(2):313-27. PubMed ID: 19113844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic stability of peptidomimetics: N-methyl and aza heptapeptide analogs of a PKB/Akt inhibitor.
    Tal-Gan Y; Freeman NS; Klein S; Levitzki A; Gilon C
    Chem Biol Drug Des; 2011 Nov; 78(5):887-92. PubMed ID: 21824328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial action of prototypic amphipathic cationic decapeptides and their branched dimers.
    Dewan PC; Anantharaman A; Chauhan VS; Sahal D
    Biochemistry; 2009 Jun; 48(24):5642-57. PubMed ID: 19432402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short cationic antimicrobial peptides bind to human alpha-1 acid glycoprotein with no implications for the in vitro bioactivity.
    Sivertsen A; Brandsdal BO; Svendsen JS; Andersen JH; Svenson J
    J Mol Recognit; 2013 Oct; 26(10):461-9. PubMed ID: 23996488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.